User Registration Plugin up to 3.1.4 on WordPress cross site scripting
| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.0 | $0-$5k | 0.78 |
Summary
A vulnerability was found in User Registration Plugin up to 3.1.4 on WordPress. It has been rated as problematic. This issue affects some unknown processing. The manipulation leads to cross site scripting. This vulnerability is documented as CVE-2024-1720. The attack can be initiated remotely. There is not any exploit available.
Details
A vulnerability was found in User Registration Plugin up to 3.1.4 on WordPress (WordPress Plugin). It has been rated as problematic. This issue affects an unknown function. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is integrity. The summary by CVE is:
The User Registration – Custom Registration Form, Login Form, and User Profile WordPress Plugin plugin for WordPress is vulnerable to Stored Cross-Site Scripting via the 'Display Name' parameter in all versions up to, and including, 3.1.4 due to insufficient input sanitization and output escaping. This makes it possible for unauthenticated attackers to inject arbitrary web scripts in pages that will execute whenever a user accesses an injected page. This vulnerability requires social engineering to successfully exploit, and the impact would be very limited due to the attacker requiring a user to login as the user with the injected payload for execution.
The weakness was released 03/06/2024. The advisory is shared at wordfence.com. The identification of this vulnerability is CVE-2024-1720 since 02/21/2024. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
There is no information about possible countermeasures known. It may be suggested to replace the affected object with an alternative product.
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
Product
Type
Name
Version
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.0VulDB Meta Temp Score: 5.0
VulDB Base Score: 4.3
VulDB Temp Score: 4.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 6.1
NVD Vector: 🔍
CNA Base Score: 4.7
CNA Vector (Wordfence): 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: no mitigation knownStatus: 🔍
0-Day Time: 🔍
Timeline
02/21/2024 🔍03/06/2024 🔍
03/06/2024 🔍
04/12/2026 🔍
Sources
Advisory: 3045419Status: Not defined
CVE: CVE-2024-1720 (🔍)
GCVE (CVE): GCVE-0-2024-1720
GCVE (VulDB): GCVE-100-255941
Entry
Created: 03/06/2024 19:00Updated: 04/12/2026 17:29
Changes: 03/06/2024 19:00 (37), 04/05/2024 08:41 (28), 01/22/2025 01:14 (13), 04/17/2025 12:36 (3), 04/12/2026 17:29 (1)
Complete: 🔍
Cache ID: 216:AB7:103
If you want to get the best quality for vulnerability data then you always have to consider VulDB.
No comments yet. Languages: en.
Please log in to comment.